Opportunity Information: Apply for RFA GH 13 005

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Monitoring and Evaluation of Malaria Control and Elimination Activities" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
  • This funding opportunity was created on Feb 4, 2013 and posted on Dec 18, 2012.
  • Applicants must submit their applications by Mar 18, 2013 Amended the Close Date 3/18/2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • The number of recipients for this funding is limited to 10 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Eligible Applicants The following organizations are eligible to apply Nonprofits Other Than Institutions of Higher Education For Profit Organizations Small Businesses For Profit Organizations (Other than Small Businesses) Higher Education Institutions Public/State Controlled Institutions of higher Education Private Institutions of Higher Education Other Native American tribal organizations (other than federally recognized tribal governments Faith based or Community based Organizations Regional Organizations Foreign Organizations a Foreign Organization is a public or private organization, whether non profit or for profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of project staff or place of performance. Bona Fide Agents a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov. Federally Funded Research and Development Centers (FFRDCs) FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not for profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long term research or development need which cannot be met as effectively by an agency s existing in house or contractor resources. FFRDCs enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to http://ecfr.gpoaccess.gov/cgi/t/text/text idxcecfrsid512ff78311f427c00454772dcf21523argndiv8viewtextnode481.0.1.6.34.0.1.18idno48. 2. Foreign Organizations Foreign Organizations are eligible to apply. Foreign components of U.S. Organizations are eligible to apply.
Apply for RFA GH 13 005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

This CDC funding opportunity (RFA GH 13 005), titled "Monitoring and Evaluation of Malaria Control and Elimination Activities," is a discretionary cooperative agreement focused on strengthening how malaria programs generate and use evidence. The core goal is to support operational research, surveillance, and monitoring and evaluation (M&E) activities carried out in close collaboration with national malaria control programs and other partners. The geographic emphasis is on two high-priority regions: the Greater Mekong Subregion (GMS) in Southeast Asia and countries in sub-Saharan Africa. Rather than funding routine service delivery alone, the announcement is designed to back practical, field-oriented work that can answer real program questions, improve decision-making, and ultimately reduce malaria illness and deaths while improving population health.

The program is housed within CDC's Malaria Branch and is framed around producing high-impact findings, tools, or strategies that malaria programs can apply at scale. Projects are expected to be innovative and strongly tied to program needs, such as identifying what is working, what is not, and why, and then translating those insights into better implementation. By emphasizing operational research and evaluation, the opportunity targets the gap between intervention availability and real-world performance, including how interventions are deployed, monitored, and adapted over time. The CDC also positions this work within the broader global malaria architecture through its partnership with the Roll Back Malaria (RBM) initiative, highlighting alignment with international efforts to coordinate malaria scale-up, surveillance, and evaluation in endemic settings.

Funding is provided through a cooperative agreement, which typically means CDC expects substantial involvement beyond simply issuing funds. In practice, that often implies close technical collaboration, shared planning, and coordination to ensure that research and M&E activities meet public health standards and are useful to national and global malaria stakeholders. The total estimated funding for the announcement is USD 5,000,000, with an anticipated 10 awards. The stated award ceiling is USD 1,000,000, and there is no specified award floor. There is no cost sharing or matching requirement, lowering the barrier to participation for organizations that may not have large unrestricted resources.

Eligibility is broad and includes a wide range of organizational types. Eligible applicants include nonprofits that are not institutions of higher education, for-profit organizations (including small businesses and other for-profit entities), institutions of higher education (public/state-controlled and private), faith-based and community-based organizations, regional organizations, Native American tribal organizations (other than federally recognized tribal governments), and federally funded research and development centers (FFRDCs). Importantly, foreign organizations are explicitly eligible to apply, and foreign components of U.S. organizations are also eligible, which fits the program's focus on malaria-endemic regions outside the United States. The announcement also allows applications from bona fide agents applying on behalf of state or local governments, provided they submit a legally binding agreement documenting that status.

Key dates show that the opportunity was posted on December 18, 2012, created on February 4, 2013, and originally closed on February 8, 2013, but the closing date was amended to March 18, 2013. The archive date is April 17, 2013, indicating it is no longer an active solicitation but remains relevant as a reference for the CDC's approach and priorities in malaria surveillance and evaluation funding. The CFDA listing is 93.283 under the Centers for Disease Control and Prevention, described as "Investigations and Technical Assistance," which reinforces that the program is about applied public health investigation and technical partnership rather than standalone academic research.

For applicants or interested organizations that need help accessing the full announcement details, the listed point of contact is the CDC Procurement and Grants Office Technical Information Management team, reachable by phone at (770) 488-2700 or by email at pgotim@cdc.gov.

Frequently Asked Questions (FAQs): CDC RFA GH 13 005 - Monitoring and Evaluation of Malaria Control and Elimination Activities

1) What is the title and identifier of this CDC funding opportunity?

The opportunity is titled "Monitoring and Evaluation of Malaria Control and Elimination Activities" and is identified as RFA GH 13 005.

2) What type of funding mechanism is this?

This is a discretionary cooperative agreement. A cooperative agreement typically means CDC expects to have substantial involvement in the work beyond providing funds, such as technical collaboration, shared planning, and coordination.

3) What is the main purpose of the program?

The core purpose is to strengthen how malaria programs generate and use evidence by supporting operational research, surveillance, and monitoring and evaluation (M&E) activities carried out in close collaboration with national malaria control programs and other partners.

4) What kinds of activities does the announcement emphasize?

The announcement emphasizes practical, field-oriented work including:

  • Operational research tied to real program questions
  • Surveillance activities that improve understanding of malaria trends and performance
  • Monitoring and evaluation work that helps determine what is working, what is not, and why
  • Generating findings, tools, or strategies that malaria programs can apply at scale

5) Is this funding meant for routine service delivery?

No. The opportunity is described as being designed to back practical, applied research and M&E, rather than funding routine service delivery alone.

6) What outcomes is this program trying to influence?

The program aims to improve decision-making and implementation in malaria programs in ways that help reduce malaria illness and deaths and improve population health, by closing the gap between intervention availability and real-world performance.

7) Where within CDC is this program housed?

The program is housed within the CDC Malaria Branch.

8) What geographic regions are a priority for this opportunity?

The geographic emphasis is on two high-priority regions:

  • The Greater Mekong Subregion (GMS) in Southeast Asia
  • Countries in sub-Saharan Africa

9) How does this opportunity relate to global malaria partners and initiatives?

The announcement positions this work within the broader global malaria architecture through CDC's partnership with the Roll Back Malaria (RBM) initiative, highlighting alignment with international efforts to coordinate malaria scale-up, surveillance, and evaluation in endemic settings.

10) How much total funding is estimated under this announcement?

The total estimated funding for the announcement is USD 5,000,000.

11) How many awards were anticipated?

The announcement anticipated approximately 10 awards.

12) What is the maximum award amount (ceiling)?

The stated award ceiling is USD 1,000,000.

13) Is there a minimum award amount (floor)?

No. The announcement states there is no specified award floor.

14) Is cost sharing or matching required?

No. The announcement states there is no cost sharing or matching requirement.

15) Who is eligible to apply?

Eligibility is broad and includes:

  • Nonprofits that are not institutions of higher education
  • For-profit organizations (including small businesses and other for-profit entities)
  • Institutions of higher education (public/state-controlled and private)
  • Faith-based and community-based organizations
  • Regional organizations
  • Native American tribal organizations (other than federally recognized tribal governments)
  • Federally funded research and development centers (FFRDCs)

16) Are foreign organizations eligible?

Yes. Foreign organizations are explicitly eligible to apply, and foreign components of U.S. organizations are also eligible.

17) Can agents apply on behalf of state or local governments?

Yes. Applications are allowed from bona fide agents applying on behalf of state or local governments, provided they submit a legally binding agreement documenting their status as an agent.

18) What does "cooperative agreement" imply for how the work will be carried out?

Based on the description provided, it implies CDC expects close collaboration, including technical involvement and coordination, to help ensure the operational research and M&E meet public health standards and are useful to national and global malaria stakeholders.

19) When was the opportunity posted and when did it close?

The opportunity was posted on December 18, 2012. It originally closed on February 8, 2013, but the closing date was amended to March 18, 2013.

20) Is this opportunity still open?

No. The archive date is April 17, 2013, indicating it is not an active solicitation and remains available as a reference.

21) What is the CFDA number and program description?

The CFDA listing is 93.283 under the Centers for Disease Control and Prevention, described as "Investigations and Technical Assistance", reinforcing the applied investigation and technical partnership focus.

22) Who can be contacted for help accessing the full announcement details?

The listed point of contact is the CDC Procurement and Grants Office Technical Information Management (PGO TIM) team. They can be reached by phone at (770) 488-2700 or by email at pgotim@cdc.gov.

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Technological Improvements to Data Collection in NIDDK Kidney and Urology Clinical Studies (SBIR) (R41/R42)

Previous opportunity: Improved Biomaterials for Urinary and Dialysis Catheters (SBIR) (R43/R44)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA GH 13 005

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA GH 13 005) also looked into and applied for these:

Funding Opportunity
Prevalence and Incidence of Inflammatory Bowel Disease Apply for RFA DP 13 001

Funding Number: RFA DP 13 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $550,000
NIDCD Small Grant Program (R03) Apply for PAR 13 057

Funding Number: PAR 13 057
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Estimating the Costs of Supporting Primary Care Practice Transformation (R03) Apply for RFA HS 13 003

Funding Number: RFA HS 13 003
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $100,000
Strengthening Public Health and the Public Health Laboratory System of Cambodia under the Presidents Emergency Plan for AIDS Relief Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1305

Funding Number: CDC RFA GH13 1305
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $350,000
HIT Capacity Building Initiative for Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Grantees Apply for HRSA 13 152

Funding Number: HRSA 13 152
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $100,000
R40 MCH Autism Intervention Research Apply for HRSA 13 195

Funding Number: HRSA 13 195
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $300,000
Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the Presidents Em Apply for CDC RFA GH13 1303

Funding Number: CDC RFA GH13 1303
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,500,000
Strengthening Global Animal Human Interface Activities for Avian Influenza and other Zoonotic Diseases Apply for RFA CK 13 002

Funding Number: RFA CK 13 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $500,000
Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region Apply for RFA IP 13 002

Funding Number: RFA IP 13 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,000,000
Grants to States to Support Oral Health Workforce Activities Apply for HRSA 13 142

Funding Number: HRSA 13 142
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $500,000
Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1304

Funding Number: CDC RFA GH13 1304
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $12,000,000
NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 062

Funding Number: PAR 13 062
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 13 001

Funding Number: CMS 1A1 13 001
Agency: Centers for Medicare Medicaid Services
Category: Health
Funding Amount: $3,000,000
Interdisciplinary Complementary and Integrative Health Clinical Research Training Award (T90/R90) Apply for PAR 13 065

Funding Number: PAR 13 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa Apply for RFA GH 13 002

Funding Number: RFA GH 13 002
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $9,000,000
Exemplar Health Information Exchange Governance Entities Program Apply for HIEGE HG 12 001

Funding Number: HIEGE HG 12 001
Agency: Office of the National Coordinator
Category: Health
Funding Amount: $400,000
Research in latent tuberculosis infection (LTBI) in the setting of HIV Co Infection (R01) Apply for PAR 13 061

Funding Number: PAR 13 061
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Integrating Newborn Screening Long term Follow up into Primary Care Practices Apply for HRSA 13 213

Funding Number: HRSA 13 213
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $110,000
Limited Competition Initiative to Maximize Research Education in Genomics (R25) Diversity Action Plan Apply for PAR 13 063

Funding Number: PAR 13 063
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building healthcare practitioner capacity around HPV Vaccine Communication Apply for RFA IP 13 001

Funding Number: RFA IP 13 001
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 13 005", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.